InvestorsHub Logo
Followers 468
Posts 26926
Boards Moderated 2
Alias Born 09/11/2006

Re: surf1944 post# 874

Wednesday, 12/12/2012 9:37:33 AM

Wednesday, December 12, 2012 9:37:33 AM

Post# of 923
8:31AM YM BioSciences to be acquired by Gilead Sciences (GILD) for $2.95 per share in cash (YMI) 1.63 : The transaction has received the unanimous approval of YM's Board of Directors, and values YM at ~ $510 million, with YM reporting CAD125.5 million in cash and cash equivalents as of Sep 30, 2012. Gilead plans to fund the acquisition with cash on hand. The transaction is expected to close in the first quarter of 2013.